Home SurModics

SurModics

In operation
IPO
Clinical Diagnostic Product Developer, Disease Monitoring Provider

Basic Information

SurModics is committed to the research and development of clinical diagnostic products, biopharmaceuticals, and scientific research products. It offers a variety of research products, including protein stabilizers, chromogenic substrates and chemiluminescent substrates, DNA and protein chips, recombinant autoimmunity antigens, auxiliary reagents such as secondary antibodies, blocking reagents, stop solutions, and more. The company aims to improve lives by providing disease detection and treatment solutions. Following two recent acquisitions, the company is transforming its medical device business from being a coating technology provider to offering comprehensive product solutions. Throughout this process, SurModics’ mission remains: to improve disease detection and treatment by addressing difficult medical device and diagnostic challenges with our technology.
Surmodics, Inc.
Minnesota,United States of America
51~100 people
January 01, 1979
--